Elite Pharmaceuticals Inc (ELTP)

[Couch]

MORE GOOD NEWS: • Abuse-deterrent formulas. FDA is preparing for an expected onslaught of generic versions of these drugs — which currently don't exist — and will release guidance for drugmakers soon. Abuse-deterrent drugs can actually lead to riskier behavior, as FDA learned with the drug Opana ER. FDA asked the maker of the purportedly safer opioid to withdraw it in June because a reformulated version led users to inject it. That led one Indiana county to have the highest number of HIV cases in the U.S.

Elite has filed the first generic ADT opioid.

https://www.usatoday.com/story/news/politics/2017/10/23/fda-chief-supports-opioid-prescription-limits-regrets-agencys-prior-inaction/774007001/